ConMed Corp. (NYSE: CNMD), a surgical-device maker founded in the Utica area, announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the third quarter. The dividend is payable on Oct. 5 to all shareholders of record as of Sept. 15. ConMed manufactures surgical devices and equipment for […]
ConMed Corp. (NYSE: CNMD), a surgical-device maker founded in the Utica area, announced that its board of directors has declared a quarterly cash dividend of 20 cents a share for the third quarter.
The dividend is payable on Oct. 5 to all shareholders of record as of Sept. 15.
ConMed manufactures surgical devices and equipment for minimally invasive procedures. The firm’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed in late July reported sales of more than $255 million in the second quarter, up almost 62 percent from the year-ago quarter. Based on the second-quarter results, the company increased its guidance for the full year of 2021 and now expects to generate revenue between $1.015 billion and $1.035 billion, an improvement from its prior guidance of between $1 billion and $1.03 billion.
ConMed now expects to produce net earnings per share in the range of $3.15 to $3.25 for 2021, an improvement from its prior range of $3.05 to $3.20.
ConMed, which was headquartered in the Utica area for 50-plus years, on Jan. 1 designated Largo, Florida (the Tampa Bay area) as its corporate headquarters. Its Utica–area facility is located at 525 French Road in New Hartford, where the company continues to maintain its manufacturing, finance, human resources, legal, and other corporate functions. The Florida office houses its CEO and other key executives.
Post
Share
Tweet
Print
Email
Get our email updates
Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.
